Comparable strategies needed to evaluate human papillomavirus vaccine efficiency across Europe

K Soldan; J Dillner

doi:10.2807/esw.11.47.03085-en

Articles Open Access

Like 0

This item has no PDF Download

Comparable strategies needed to evaluate human papillomavirus vaccine efficiency across Europe
K Soldan , J Dillner
View Citation Hide Citation

Citation style for this article: Soldan K, Dillner J. Comparable strategies needed to evaluate human papillomavirus vaccine efficiency across Europe. Euro Surveill. 2006;11(47):pii=3085. https://doi.org/10.2807/esw.11.47.03085-en

Abstract

A quadrivalent vaccine against human papillomavirus types 16, 18, 6 and 11, known as Gardasil was granted a marketing license by the European Commission in September 2006